Peter Burkhard

Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge.

Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.

Self-assembling protein nanoparticles: a promising tool against lethal influenza?

The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.

Protein nanovaccine confers robust immunity against .

A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.